Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 8:29 PM UTC
| NCT Number | NCT06679829 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | PHASE2 |
| Target Enrollment | 215 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Last Updated on CT.gov | April 24, 2026 (Apr 24, 2026) |
As of July 17, 2026: Clinical trial NCT06679829 is currently recruiting participants. This phase2 study for multiple myeloma is actively seeking new participants at 7 locations across the United States. The study is sponsored by Memorial Sloan Kettering Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06679829 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06679829 was last updated Apr 24, 2026 (April 24, 2026). HelloStudys verifies this status automatically.